by Pete Celano | May 26, 2026 | Blog
This May 26, 2026 article cleverly titled “From Margin to Mainstream: Why Liver Health Should Sit at the Centre of the Global NCD Response” by Jeffrey Lazarus in Health Policy Watch is a call to (overdue) action.Jeffrey Lazarus is the Professor of Global...
by David Sires | May 24, 2026 | Blog
It’s a complex organ–1. Your liver can regenerate itselfIt’s the only internal organ that can regrow lost tissue. Even if up to about 70% is removed, it can regenerate back to near-full size within months. 2. It’s your body’s largest internal organThe...
by Pete Celano | May 23, 2026 | Blog
Big Gilead news: “FDA Grants Accelerated Approval to Gilead’s Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)”. Gilead announced that the FDA has granted accelerated approval to Hepcludex...
by David Sires | May 19, 2026 | Blog
The article titled “Hepatitis C Treatment Could Save Billions” explains that expanding access to HCV treatment—especially among Medicaid patients—could generate major long-term healthcare savings while dramatically improving patient outcomes. Key Takeaways...
by Brandon Tudor | May 17, 2026 | Blog
This May 16, 2026 Cureus review titled “Metabolic Dysfunction-Associated Steatotic Liver Disease: Current Diagnostic Pathways, Noninvasive Fibrosis Assessment, and Therapeutic Strategies” is essentially a “state of the field” overview of MASLD (formerly...
by David Sires | May 15, 2026 | Blog
